Key result
Dobutamine myocardial blood flow inversely correlated with coronary artery stenosis severity in both ischemic (r=0.79, p<0.001) and remote territories (r=0.71, p<0.001).
Why the study?
Does dobutamine-induced myocardial blood flow correlate with coronary artery stenosis severity in patients with single-vessel CAD?
Observational (n=36)
Does dobutamine-induced myocardial blood flow correlate with coronary artery stenosis severity in patients with single-vessel CAD?
Effect estimate: r = 0.79
p-value: p=<0.001
Dobutamine-induced myocardial blood flow measured by PET inversely correlates with coronary stenosis severity and demonstrates significant flow heterogeneity for stenoses >70%.
Hypothesis-generating for dobutamine PET in CAD; prospective trials needed before clinical adoption.
OBJECTIVES: To compare the relationship between dobutamine myocardial blood flow (MBF), rate-pressure product (RPP) and stenosis severity in patients with coronary artery disease (CAD). METHODS: 27 patients with single-vessel CAD were allocated to three groups based on stenosis severity: group 1, 50-69% (n = 9); group 2, 70-89% (n = 9); and group 3, >or= 90% (n = 9). Nine normal volunteers served as controls. Resting and dobutamine MBF were measured by positron emission tomography in the territory subtended by the stenosis (Isc) and remote myocardium (Rem). Mean left ventricular MBF was used for controls. RESULTS: In group 1, mean dobutamine MBF-Isc (2.48 (SD 0.48 ml/min/g)) and dobutamine MBF-Rem (2.70 (0.50) ml/min/g, NS) were comparable. In groups 2 and 3, dobutamine MBF-Isc (1.91 (0.44) and 1.22 (0.21) ml/min/g) was significantly lower than dobutamine MBF-Rem (2.27 (0.28) and 1.98 (0.25) ml/min/g, p < 0.02 and p < 0.005, respectively). An inverse relation between dobutamine MBF and stenosis severity existed both in Isc (r = 0.79, p < 0.001) and in Rem territories (r = 0.71, p < 0.001). For any given RPP, dobutamine MBF was greater in controls than in Rem (p < 0.05), which in turn was greater than in Isc (p < 0.05). CONCLUSION: Dobutamine MBF inversely correlated with stenosis severity and achieved significant flow heterogeneity for coronary stenoses > 70%. Dobutamine MBF and RPP were dissociated in both Isc and Rem segments in patients compared with controls.
No takes yet. Share an insight, caveat, or question.
Rohan Jagathesan (2006) conducted an observational in Coronary artery disease (n=36). Coronary artery stenosis severity vs. Normal volunteers was evaluated on Relationship between dobutamine myocardial blood flow and stenosis severity (r = 0.79, p=<0.001). Dobutamine myocardial blood flow inversely correlated with coronary artery stenosis severity in both ischemic (r=0.79, p<0.001) and remote territories (r=0.71, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: